Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with oral danazol and steroid

Rheumatology International

Volumn 25, Issue 5, 2005, Pages 388-390

  Chan, Alice Y K ^a   Li, Edmund K ^a   Tam, L S ^a   Cheng, Gregory ^a   Choi, Paul C L ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Oral danazol; Red cell aplasia; Systemic lupus erythematosus

Indexed keywords

CEFUROXIME; DANAZOL; ETHAMBUTOL; HYDROXYCHLOROQUINE; ISONIAZID; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; STEROID; TUBERCULOSTATIC AGENT;

ADULT; ANAMNESIS; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CHINESE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG WITHDRAWAL; ERYTHROCYTE APLASIA; FEMALE; GRANULOMATOUS INFLAMMATION; HUMAN; INFECTION; LABORATORY TEST; LOW DRUG DOSE; PRIORITY JOURNAL; PROTEINURIA; PURE RED CELL ANEMIA; RECURRENT DISEASE; SEROLOGY; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSFUSION;

ADMINISTRATION, ORAL; DANAZOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ESTROGEN ANTAGONISTS; FEMALE; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PREDNISOLONE; RED-CELL APLASIA, PURE; TREATMENT OUTCOME;

EID: 21544482844     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-004-0521-6     Document Type: Article

References (13)

1. Choi BG, Yoo WH (2002) Successful treatment of pure red cell aplasia with plasmapheresis in a patient with systemic lupus erythematosus. Yonsei Med J 43(2):274-278
2. Kiely PD, McGuckin CP, Collins DA, Bevan DH et al (1995) Erythrocyte aplasia and systemic lupus erythematosus. Lupus 4:407-411
3. Linardaki GD, Boki KA, Fartakis A, Tzioufas AG (1999) Pure red cell aplasia as presentation of systemic lupus erythematosus: Antibodies to erythropoietin. Scand J Rheumatol 28:189-191
4. Abkowitz JL, Kadin ME, Powell JS, Adamson JW (1986) Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br J Haematol 63:59-67
5. Clark DA, Dessypris EN, Krantz SB (1984) Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood 63:277
6. Winkler A, Jackson RW, Kay DS (1988) High dose intravenous cyclophosphamide treatment of systemic lupus erythematosus associated aplastic anemia. Arthritis Rheum 31:693
7. Duarte-Salazar C, Cazarin-Barrientos J, Goycochea-Robles MV, Collazo-Jaloma J et al (2000) Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A. Rheumatol 39:1155-1157
8. Ilan Y, Naparstek Y (1993) Pure red cell aplasia associated with systemic lupus erythematosus: remission after a single course of intravenous immunoglobulin. Acta Haematol 89:152-154
9. Lippman SM, Durie BGM, Garewal HS, Giordano G et al (1986) Efficacy of danazol in pure red cell aplasia. Am J Hematol 23:373-379
10. Roubinian JR, Papoian R, Talal N (1977) Androgenic hormones modulate autoantibody responses and improve survival in murine lupus. J Clin Invest 59:1066-1070
11. Roubinian JR, Talal N, Greenspan JS, Goodman JR et al (1978) Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 147:1568-1583
12. Michalski JP, McCombs CC, Roubinian JR, Talal N (1983) Effect of androgen therapy on survival and suppressor cell activity in aged NZB/NZW F1 hybrid mice. Clin Exp Immunol 52:229-233
13. Stein CM (2001) Immunoregulatory drugs. In: Ruddy S (ed) Kelley's Textbook of Rheumatology. W.B. Saunders, Philadelphia, pp 879-898